Hundreds Of Researchers Urge Supreme Court To Follow Science On Abortion Pill

A group of more than 260 members of Congress also submitted a friend-of-the-court brief ahead of the mifepristone hearing in March.

More than 300 reproductive health researchers urged the Supreme Court to follow the science when they hear arguments on mifepristone, a drug used in medication abortion that is under attack by Republican lawmakers and conservative courts.

While detractors have cast doubt on mifepristone’s safety and effectiveness, the researchers said there is “ample scientific evidence” to support its widespread availability under guidelines set out by the Food and Drug Administration.

Separately, a group of 263 members of Congress submitted a brief imploring the high court to respect the FDA’s authority — given by Congress — to regulate drugs like mifepristone.

“This Court should not allow the politics of abortion to obscure the clear, abundant, and plainly sufficient scientific record supporting FDA’s decision-making in this case,” the scientists’ brief said.

Those who signed the statement included medical professors, medical doctors, principal researchers, postdoctoral researchers and others hailing from a variety of top institutions, including the University of California, Los Angeles, Brown University, Rutgers University, Johns Hopkins University and the Guttmacher Institute.